Study of Intensive Care Unit (ICU)-Acquired Weakness (Handgrip Strength Study)
NCT ID: NCT00702000
Last Updated: 2016-01-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
49 participants
OBSERVATIONAL
2008-05-31
2010-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Diagnosing Intensive Care Unit (ICU) Acquired Weakness
NCT04166630
Hand Grip Strength and Medical Research Council Scale as Predictors of Weaning Failure
NCT03991702
IMT Outcomes in Sufferers of Severe Walking Disabilities and Intensive Care Unit Acquired Weakness
NCT06210763
Early Assessment of Quadriceps Muscle Recovery by Dynamometry and 3D Ultrasound in Intensive Care Patients Under Invasive Mechanical Ventilation
NCT07069959
Inspiratory Muscle Training in Mechanically Ventilated Patients in Intensive Care Unit
NCT06609564
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
To begin to develop this hypothesis, a better understanding of the determinants of handgrip strength needs to be developed. As a result we propose to perform a prospective observational study examining the clinical factors that are associated with handgrip strength. Several clinical factors are known to be associated with increased risk of developing ICUAP while hospitalized: multiple organ failure, severe sepsis, female gender and treatments like steroids. As many of these risk factors are not modifiable, the opportunity to intervene is unclear. However, by attempting to better describe the spectrum of strength deficits experienced by critically ill patients we may better be able to dissect and prevent ICUAP.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1.
Those with ICU-acquired weakness
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age ≥ 18 years of age at ICU admit.
* Requiring mechanical ventilation for at least 24 hours
Exclusion Criteria
* Patient, family or physicians not in favor of continued support until awakening.
* Profound neurologic injury associated with little or no chance of awakening.
* Active consideration of a diagnosis of brain death by treating physicians.
* Known history of chronic neurological disease resulting in muscle weakness in more than two limbs.
* Inability to perform handgrip dynamometry prior to acute illness.
* Subject is a Non-english speaker
* Subject or surrogate unable to provide informed consent.
* ICU stay of greater than 24 hours within the last thirty days or at any point during the current hospitalization
* Greater than seven days of hospital care prior to hospital admission.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Naeem Ali, MD
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Naeem Ali, MD
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Naeem A. Ali, M.D.
Role: PRINCIPAL_INVESTIGATOR
Ohio State University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Ohio State University
Columbus, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2008H0081
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.